Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
European Surgery
Erschienen in:

25.04.2018 | main topic

Technical advances and future perspectives in liver surgery

verfasst von: Marc A. Ward, MD, Brice Gayet, MD, PhD, Nicolas Tabchouri, MD, Fabrizio Moisan, MD, Gianfranco Donatelli, MD, Stefan Stättner, MD, FRCS (Eng), FEBS (HPB), Prof. David Fuks, MD, PhD

Erschienen in: European Surgery | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Summary

The current era of liver surgery is highlighted by low morbidity and mortality rates, innovative efforts to increase resectability, and overall improved survival for patients with both primary and metastatic lesions. The complexity of liver anatomy combined with the presence of several major vascular structures delayed the widespread application of minimally invasive surgical techniques to liver surgery compared to other intra-abdominal organs. However, our experience with minimally invasive surgery has greatly expanded over the past 20 years. Modern surgical techniques, emerging technologies, and novel chemotherapeutic agents have led to a significant increase in minimally invasive liver surgery worldwide. This review will focus on the modern technical advancements that make minimally invasive liver surgery successful and what we can expect in the future.
Vorheriger Artikel Shaping the future of liver surgery
Literatur
1.
Ito K, Govindarajan A, Ito H, Fong Y. Surgical treatment of hepatic colorectal metastasis evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century. Cancer J. 2010;16:103–10.CrossRefPubMed
2.
Norero E, Jarufe N, Butte JM, Norero B, Duarte I, Torres J, et al. Outcome of surgical treatment of liver metastasis from colorectal cancer. Rev Med Chil. 2009;137:487–96.CrossRefPubMed
3.
Hashizume M, Takenaka K, Yanaga K, Ohta M, Kajiyama K, Shirabe K, et al. Laparoscopic hepatic resection for hepatocellular carcinoma. Surg Endosc. 1995;9:1289–91.CrossRefPubMed
4.
Rau HG, Meyer G, Cohnert TU, Schardey HM, Jauch K, Schildberg FW. Laparoscopic liver resection with the water-jet dissector. Surg Endosc. 1995;9:1009–12.CrossRefPubMed
5.
Wakabayashi G, Cherqui D, Geller DA, Buell JF, Kaneko H, Han HS, et al. Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg. 2015;261:619–29.PubMed
6.
Wakabayashi G, Cherqui D, Geller DA, Han HS, Kaneko H, Buell JF. Laparoscopic hepatectomy is theoretically better than open hepatectomy: preparing for the 2nd International Consensus Conference on Laparoscopic Liver Resection. J Hepatobiliary Pancreat Sci. 2014;21:723–31.CrossRefPubMed
7.
Belghiti J, Guevara OA, Noun R, Saldinger PF, Kianmanesh R. Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization. J Am Coll Surg. 2001;193:109–11.CrossRefPubMed
8.
Topal H, Tiek J, Aerts R, Topal B. Outcome of laparoscopic major liver resection for colorectal metastases. Surg Endosc. 2012;26:2451–5.CrossRefPubMed
9.
Nguyen KT, Marsh JW, Tsung A, Steel JJ, Gamblin TC, Geller DA. Comparative benefits of laparoscopic vs open hepatic resection: a critical appraisal. Arch Surg. 2011;146:348–56.CrossRefPubMed
10.
Chen HY, Juan CC, Ker CG. Laparoscopic liver surgery for patients with hepatocellular carcinoma. Ann Surg Oncol. 2008;15:800–6.CrossRefPubMed
11.
Topal B, Fieuws S, Aerts R, Vandeweyer H, Penninckx F. Laparoscopic versus open liver resection of hepatic neoplasms: comparative analysis of short-term results. Surg Endosc. 2008;22(10):2208–13.CrossRefPubMed
12.
Xiong JJ, Altaf K, Javed MA, Huang W, Mukherjee R, Mai G, Sutton R, Liu XB, Hu WM. Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma. World J Gastroenterol. 2012;18:6657–68.CrossRefPubMedPubMedCentral
13.
Lo’pez-Ben S, Palacios O, Codina-Barreras A, Albiol MT, Falgueras L, Castro E, Figueras J. Pure laparoscopic liver resection reduces surgical site infections and hospital stay. Results of a case-matched control study in 50 patients. Langenbecks Arch Surg. 2014;399:307–14.CrossRef
14.
Tranchart H, Di Giuro G, Lainas P, Roudie J, Agostini H, Franco D, Dagher I. Laparoscopic resection for hepatocellular carcinoma: a matched-pair comparative study. Surg Endosc. 2010;24:1170–6.CrossRefPubMed
15.
Truant S, Bouras AF, Hebbar M, Boleslawski E, Fromont G, Dharancy S, Leteurtre E, Zerbib P, Pruvot FR. Laparoscopic resection vs. open liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: a casematched study. Surg Endosc. 2011;25:3668–77.CrossRefPubMed
16.
Nguyen KT, Gamblin TC, Geller DA. World review of laparoscopic liver resection – 2,804 patients. Ann Surg. 2009;250:831–41.CrossRefPubMed
17.
Gayet B, Cavaliere D, Vibert E, Perniceni T, Levard H, Denet C, et al. Totally laparoscopic right hepatectomy. Am J Surg. 2007;194:685–9.CrossRefPubMed
18.
Kitisin K, Packiam V, Bartlett DL, Tsung A. A current update on the evolution of robotic liver surgery. Minerva Chir. 2011;66:281–93.PubMed
19.
20.
Casciola L, Patriti A, Ceccarelli G, Bartoli A, Ceribelli C, Spaziani A. Robot-assisted parenchymal-sparing liver surgery including lesions located in the posterosuperior segments. Surg Endosc. 2011;25:3815–24.CrossRefPubMed
21.
Giulianotti PC, Coratti A, Sbrana F, Addeo P, Bianco FM, Buchs NC, et al. Robotic liver surgery: results for 70 resections. Surgery. 2011;149:29–39.CrossRefPubMed
22.
Lai EC, Tang CN, Li MK. Robot-assisted laparoscopic hemihepatectomy: technique and surgical outcomes. Int J Surg. 2012;10:11–5.CrossRefPubMed
23.
Choi GH, Choi SH, Kim SH, Hwang HK, Kang CM, Choi JS, et al. Robotic liver resection: technique and results of 30 consecutive procedures. Surg Endosc. 2012;26:2247–58.CrossRefPubMed
24.
Tsung A, Geller DA, Sukato DC, Sabbaghian S, Tohme S, Steel J, et al. Robotic versus laparoscopic hepatectomy: a matched comparison. Ann Surg. 2014;259:549–55.CrossRefPubMed
25.
van der Vorst JR, Schaafsma BE, Hutteman M, et al. Nearinfrared fluorescence-guided resection of colorectal liver metastases. Cancer. 2013;119(18):3411–8.CrossRefPubMedPubMedCentral
26.
Ishizawa T, Masuda K, Urano Y, et al. Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma. Ann Surg Oncol. 2014;21(2):440–8.CrossRefPubMed
27.
Lim C, Vibert E, Azoulay D, et al. Indocyanine green fluorescence imaging in the surgical management of liver cancers: ICG Imaging in surgical oncology current facts and future implications. J Visc Surg. 2014;151(2):117–24.CrossRefPubMed
28.
Velayutham V, Fuks D, Nomi T, Kawaguchi Y, Gayet B. 3D visualization reduces operating time when compared to high-definition 2D in laparoscopic liver resection: a case-matched study. Surg Endosc. 2016;30(1):147–53.CrossRefPubMed
29.
Wauben LSGL, van Veelen MA, Gossot D, Goossens RHM. Application of ergonomic guidelines during minimally invasive surgery: a questionnaire survey of 284 surgeons. Surg Endosc. 2006;20:1268–74.CrossRefPubMed
30.
Zahraee AH, Paik JK, Szewcyzk J, Morel G. Towards the development of a hand-held surgical robot for laparoscopy. IEEE/ASME Trans Mechatron. 2010;15:853–86.
31.
Herman B, Zahraee AH, Szewczyk J, Morel G, Bourdin C, Vercher J‑L, Gayet B. Ergonomic and gesture performance of robotized instruments for laparoscopic surgery. IEEE/RSJ Int Conf Intell Robot Syst. 2011;2011:1333–8.
32.
Bensignor T, Morel G, Reversat D, Fuks D, Gayet B. Evaluation of the effect of a laparoscopic robotized needle holder on ergonomics and skills. Surg Endosc. 2016;30(2):446–54.CrossRefPubMed
33.
Kenngott HG, Wagner M, Gondan M, Nickel F, Nolden M, Fetzer A, et al. Real-time image guidance in laparoscopic liver surgery: first clinical experience with a guidance system based on intraoperative CT imaging. Surg Endosc. 2014;28:933–40.CrossRefPubMed
34.
Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM, McWilliams RR. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27:3677–83.CrossRefPubMedPubMedCentral
35.
Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818–25.CrossRefPubMedPubMedCentral
36.
Domont J, Pawlik TM, Boige V, Rose M, Weber JC, Hoff PM, Brown TD, Zorzi D, Morat L, Pignon JP, Rashid A, Jaeck D, Sabatier L, Elias D, Tursz T, Soria JC, Vauthey JN. Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis. J Clin Oncol. 2005;23:3086–93.CrossRefPubMed
37.
Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring systemto improve case selection, based on 1568 patients. Cancer. 1996;77:1254–62.CrossRefPubMed
38.
Rees M, Tekkis PP, Welsh FK, O’Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247:125–35.CrossRefPubMed
39.
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371:1007–16.CrossRefPubMedPubMedCentral
40.
Blazer DG 3rd, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ, Fogelman D, Eng C, Chang DZ, Wang H, Zorzi D, Ribero D, Ellis LM, Glover KY, Wolff RA, Curley SA, Abdalla EK, Vauthey JN. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol. 2008;26:5344–51.CrossRefPubMed
41.
Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J, Bardelli A. Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst. 2009;101:1308–24.CrossRefPubMedPubMedCentral
42.
Vauthey JN, Zimmitti G, Kopetz SE, Shindoh J, Chen SS, Andreou A, Curley SA, Aloia TA, Maru DM. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Ann Surg. 2013;258:619–26.CrossRefPubMed
43.
Brudvik KW, Kopetz SE, Li L, Conrad C, Aloia TA, Vauthey JN. Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases. Br J Surg. 2015;102:1175–83.CrossRefPubMed
44.
Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, Andreou A, Loyer EM, Madoff DC, Curley SA, Vauthey JN. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011;29:1083–90.CrossRefPubMedPubMedCentral
Metadaten
Titel
Technical advances and future perspectives in liver surgery
verfasst von
Marc A. Ward, MD
Brice Gayet, MD, PhD
Nicolas Tabchouri, MD
Fabrizio Moisan, MD
Gianfranco Donatelli, MD
Stefan Stättner, MD, FRCS (Eng), FEBS (HPB)
Prof. David Fuks, MD, PhD
Publikationsdatum
25.04.2018
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 3/2018
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-018-0530-4

Weitere Artikel der Ausgabe 3/2018

Integrating interventional oncology in the treatment of liver tumors

  • Open Access
  • main topic

Indications for liver surgery in benign tumours

  • Open Access
  • main topic

Perioperative management of liver surgery—review on pathophysiology of liver disease and liver failure

  • Open Access
  • main topic

Optimal perioperative care in peri-hilar cholangiocarcinoma resection

  • Open Access
  • main topic

Surgical techniques and strategies for the treatment of primary liver tumours: hepatocellular and cholangiocellular carcinoma

  • Open Access
  • main topic

Shaping the future of liver surgery

  • Open Access
  • main topic